Navigation Links
Valeant Pharmaceuticals Reports 2011 Second Quarter Financial Results
Date:8/4/2011

MISSISSAUGA, Ontario, Aug. 4, 2011 /PRNewswire/ --

  • 2011 Second Quarter Total Revenue $609 million, including $40 million related to Trobalt milestone
  • Total pro forma revenue growth for the combined company was approximately 27%
  • Excluding the impact of foreign exchange, acquisitions and milestones, pro forma organic growth was approximately 4%
  • Also excluding impact from Diastat and Efudex, pro forma organic growth for the combined company was approximately 7%
  • 2011 Second Quarter GAAP EPS $0.17; Cash EPS $0.73,
  • Includes $0.06 gain from Cephalon investment
  • 2011 Second Quarter GAAP Cash Flow from Operations was $227 million; Adjusted Cash Flow from Operations was $260 million  
  • 2011 Cash EPS Guidance raised to $2.70 - $3.00

  • Valeant Pharmaceuticals International, Inc. (NYSE: VRX) (TSX: VRX) announces second quarter financial results for 2011.

    “The second quarter once again demonstrated the strength of our diversified business model,” stated J. Michael Pearson, chairman and chief executive officer.  “While the organic growth in our U.S. operations faced a number of headwinds this quarter, such as a tough comparison to the second quarter of 2010 when Legacy Biovail product sales were at unusually high levels, coupled with lower than expected results delivered by partnered Legacy Biovail generic products, we still delivered solid pro forma organic growth.  We remain confident that our full year pro forma organic growth should be approximately 8 percent due in part to the strong performance from our businesses in Europe, Latin America, Canada and Australia. In addition, we are pleased to report that our cash flow from operations generation was particularly robust this quarter, demonstrating the solid execution of our
    '/>"/>

    SOURCE Valeant Pharmaceuticals International, Inc.
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19

    Related medicine technology :

    1. Valeant Pharmaceuticals Announces Approval of Sublinox® in Canada
    2. Valeant Pharmaceuticals Announces Distribution Agreement for Zuacta™ in Canada
    3. Valeant Pharmaceuticals Agrees to Acquire Ortho Dermatologics
    4. Sanofi Divests Dermik Dermatology Unit to Valeant Pharmaceuticals International, Inc.
    5. Valeant Pharmaceuticals Agrees to Acquire Dermik
    6. Valeant Pharmaceuticals Announces License Agreement With Meda for North American Rights for Elidel® and Xerese™
    7. Valeant Pharmaceuticals Reports 2011 First Quarter Financial Results
    8. Valeant Pharmaceuticals Congratulates Teva and Cephalon on Their Transaction
    9. Valeant Pharmaceuticals to Announce 2011 First Quarter Results on May 9, 2011
    10. Valeant Pharmaceuticals Responds to Cephalon Boards Letter
    11. Valeant Pharmaceuticals Announces Redemption of 4.0% Convertible Subordinated Notes Due 2013
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:7/10/2014)... Ariz. , July 10, 2014   Ventana ...  Group, today announced it has entered into an agreement ... which operates as EMD Serono in the ... , to collaborate with Merck KGaA,s biopharmaceutical division on ... for an undisclosed target using Ventana,s proprietary diagnostic assays. ...
    (Date:1/15/2014)... Jan. 15, 2014 Sono-Tek Corporation (OTC BB: SOTK) today ... 30, 2013, compared to sales of $2,202,000 for the prior ... this quarter has also shown growth over the preceding quarter,s ... of this fiscal year. Markets that experienced sales increases over ...
    (Date:1/15/2014)... , Jan. 15, 2014 AARP Foundation today announced it ... adults suffering from the severe cold weather that has gripped ... to helping those in need; so to support these emergency ... up to $250,000, which could mean up to $500,000 in ...
    Breaking Medicine Technology:Ventana Medical Systems, Inc. and Merck KGaA, Darmstadt, Germany to develop companion diagnostic test for cancer treatment 2Ventana Medical Systems, Inc. and Merck KGaA, Darmstadt, Germany to develop companion diagnostic test for cancer treatment 3Sono-Tek Announces Third Quarter Results 2Sono-Tek Announces Third Quarter Results 3Sono-Tek Announces Third Quarter Results 4AARP Foundation Establishes Winter Relief Fund for Older Adults Suffering from the Severe Cold Weather 2AARP Foundation Establishes Winter Relief Fund for Older Adults Suffering from the Severe Cold Weather 3
    ... Halozyme Therapeutics, Inc. (NASDAQ: HALO ) today announced ... common stock pursuant to an effective shelf registration statement in ... book-running manager of the offering, and Halozyme intends to grant ... an additional 1,020,000 shares of common stock. All of the ...
    ... WASHINGTON, Feb. 9, 2012 New 2012 Medicare Part ... Medicaid Services (CMS) show the growing popularity among Medicare Part ... network options. Enrollment in plans with preferred pharmacy networks has ... is offered by many of the largest Part D plan ...
    Cached Medicine Technology:Halozyme Announces Proposed Public Offering of Common Stock 2Halozyme Announces Proposed Public Offering of Common Stock 3
    (Date:7/13/2014)... ability to identify odors might indicate the development ... of the eye could indicate the build-up of ... brain, according to the results of four research ... Conference 2014 (AAIC 2014) in Copenhagen. , In ... identify odors was significantly associated with loss of ...
    (Date:7/13/2014)... 13, 2014 ECS is ... “As a parent of a special needs child, I ... the Seattle community for contemporary special education resources and ... alternative to students and families in the Seattle metro ... environment for special education. We welcome the opportunity to ...
    (Date:7/13/2014)... 2014 Recently, iFitDress.com, one of the ... occasion outfits, has added a new selection of beautiful ... company has launched a promotion for these evening gowns. ... iFitDress.com is now providing thousands of graceful gowns in ... in Britain, America, France, Italy and many other countries. ...
    (Date:7/12/2014)... The Passenger Information System market is estimated to grow ... 2019, at an expected CAGR of 26.5% for the ... infrastructure in North America is well developed and network ... of the region. The growing ridership figures in public ... are driving the North American Passenger Information System market ...
    (Date:7/12/2014)... The "North American Interventional ... by Angioplasty Balloon (Plain/Old, Cutting), Stent ... Filter (Retrievable), Endovascular Stent Graft - ... the major market drivers, restraints, and ... , Browse 108 market data tables ...
    Breaking Medicine News(10 mins):Health News:Smell and eye tests show potential to detect Alzheimer's early 2Health News:Smell and eye tests show potential to detect Alzheimer's early 3Health News:Smell and eye tests show potential to detect Alzheimer's early 4Health News:Smell and eye tests show potential to detect Alzheimer's early 5Health News:Smell and eye tests show potential to detect Alzheimer's early 6Health News:Smell and eye tests show potential to detect Alzheimer's early 7Health News:New Private School, Emerald City School, Founded in Downtown Seattle Now Accepting 1st to 6th Grade Students Who Learn Differently 2Health News:New and Beautiful Evening Dresses Unveiled by iFitDress.com 2Health News:North America Passenger Information System (ICT) Market worth $5,486.88 Million by 2019 - New Report by MicroMarket Monitor 2Health News:North America Passenger Information System (ICT) Market worth $5,486.88 Million by 2019 - New Report by MicroMarket Monitor 3Health News:North America Passenger Information System (ICT) Market worth $5,486.88 Million by 2019 - New Report by MicroMarket Monitor 4Health News:North American Interventional Cardiology & Peripheral Vascular Devices Market - New Report by MarketsandMarkets 2Health News:North American Interventional Cardiology & Peripheral Vascular Devices Market - New Report by MarketsandMarkets 3Health News:North American Interventional Cardiology & Peripheral Vascular Devices Market - New Report by MarketsandMarkets 4Health News:North American Interventional Cardiology & Peripheral Vascular Devices Market - New Report by MarketsandMarkets 5
    ... about to launch a new vaccination project to ... //The vaccination against pneumococcal meningitis will also be ... ,"Pneumococcal meningitis is very serious," Diane McConnell, manager ... effectively die or be left with very severe ...
    ... A doctor in a Bihar village was Monday battling for life ... by a snake had died during treatment. // ,Dr. ... his life at Sursand in Sitamarhi district, was in a coma, ... clinic was vandalised and set on fire by furious crowds. ...
    ... addicted to drinks too and may face emotional, behavioral ... had revealed that 70 percent children of alcoholics develop ... or gambling, while a half ended up marrying alcoholics. ... medical journal 'Priory' that reviewed existing data on crime, ...
    ... believe that they might have finally cracked the mystery ... captivity in the Top End.// ,Eye and throat ... of the Top End's five crocodile farms in recent ... said, "Preliminary data suggests the unusually cold dry season ...
    ... revealed that the number of women suffering from gestational ... 5 years.// Hence, overweight women are being advised to ... given shocking statistics. According to it, more than 18,500 ... only 4286 cases were reported in 2000. ...
    ... tissue suppliers’ scandals, the patients who received tendons, cartilage and ... tests for hepatitis and HIV. This is happening for the ... officials won’t tell the number of people, across the country, ... is difficult to tell about the risk recipients face. ...
    Cached Medicine News:Health News:Tissue implant scandal heightens FDA’s concer 2
    Each solid state catheter kit below is supplied with adapter cable(s) for Polygraf ID and a Manometric Calibrator....
    ... water perfused manometric catheters for ... diagnostic tests. All Medtronic Water ... clear, medical grade PVC tubing. ... esophagus you will find a ...
    ... Catheters make motility testing simpler ... catheters set up in seconds ... with every sensor circumferential, Air-Charged ... anatomical irregularities. For advanced performance ...
    Esophageal Stylet for LATITUDE® Air-Charged Catheter...
    Medicine Products: